NRG-HN001头颈临床试验调强放疗计划的离线质量保证:基于知识计划的研究
本研究利用NRG-HN001临床试验中50例头颈患者计划构建多机构知识计划(KBP)模型,并重新优化另50例计划。结果显示KBP计划在多数病例中改善了危及器官保护,并确立了5%处方剂量作为反馈治疗机构的OAR保护改善阈值。
要点
- KBP模型可提升头颈调强放疗计划质量,改善多个OAR的保护。
- 50例KBP计划中33例至少7个OAR的保护得到改善。
- 以5%处方剂量作为OAR保护改善阈值用于离线质量保证反馈。
核心结论
- 基于疾病部位、多机构临床试验的KBP模型改善了NRG-HN001试验中大量重新优化计划的OAR保护,并已用作离线质量保证工具。
研究设计与样本
- 使用NRG-HN001临床试验中50例头颈患者的治疗计划构建KBP模型,并用该模型重新优化另50例计划,比较提交计划与KBP计划的剂量学参数。
主要发现
- KBP计划中PTV_6996的95%剂量均值比提交计划高0.5 Gy,PTV_6996的D0.03cc均值高2.1 Gy。
- KBP计划中脑干、脊髓、右视神经、左视神经和视交叉的D0.03cc均值分别比提交计划低2.5 Gy、1.9 Gy、6.4 Gy、6.6 Gy和5.7 Gy。
- KBP计划中右腮腺和左腮腺的Dmean均值分别比提交计划低2.2 Gy和3.8 Gy。
- 50例KBP计划中有33例观察到至少7个OAR(脑干、脊髓、左右视神经、视交叉和左右腮腺)的保护改善。
关键数值与推荐
- 建立了5%处方剂量的OAR保护改善阈值,用于将质量保证结果反馈给治疗机构。
临床怎么用
- 该KBP模型可作为离线质量保证工具,用于评估和反馈头颈调强放疗计划中OAR保护的改善情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate whether a disease site-specific, multi-institutional knowledge based-planning (KBP) model can improve the quality of intensity modulated radiation therapy treatment planning for patients enrolled in the head and neck NRG-HN001clinical trial and to establish a threshold of improvements of treatment plans submitted to the clinical trial. METHODS AND MATERIALS: Fifty treatment plans for patients enrolled in the NRG-HN001 clinical trial were used to build a KBP model; the model was then used to reoptimize 50 other plans. We compared the dosimetric parameters of the submitted and KBP reoptimized plans. We compared differences between KBP and submitted plans for single- and multi-institutional treatment plans. RESULTS: Mean values for the dose received by 95% of the planning target volume (PTV_6996) and for the maximum dose (D0.03cc) of PTV_6996 were 0.5 Gy and 2.1 Gy higher in KBP plans than in the submitted plans, respectively. Mean values for D0.03cc to the brain stem, spinal cord, optic nerve_R, optic nerve_L, and chiasm were 2.5 Gy, 1.9 Gy, 6.4 Gy, 6.6 Gy, and 5.7 Gy lower in the KBP plans than in the submitted plans. Mean values for Dmean to parotid_R and parotid_L glands were 2.2 Gy and 3.8 Gy lower in KBP plans, respectively. In 33 out of 50 KBP plans, we observed improvements in sparing of at least 7 organs at risk (OARs) (brain stem, spinal cord, optic nerves (R & L), chiasm, and parotid glands [R & L]). A threshold of improvement of OARs sparing of 5% of the prescription dose was established for providing the quality assurance results back to the treating institution. CONCLUSIONS: A disease site-specific, multi-institutional, clinical trial-based KBP model improved sparing of OARs in a large number of reoptimized plans submitted to the NRG-HN001 clinical trial, and the model is being used as an offline quality assurance tool.
引用
- Giaddui T, Geng H, Chen Q, et al. Offline Quality Assurance for Intensity Modulated Radiation Therapy Treatment Plans for NRG-HN001 Head and Neck Clinical Trial Using Knowledge-Based Planning. Adv Radiat Oncol. 2020. PMID: 33305097. doi:10.1016/j.adro.2020.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。